Macro Rotation: DeepSeek's picks for 2026-10-16

DeepSeek picked XLV, XLF, TLT, XLK, XLE, XLY for a 1-day horizon. Long-short spread: -1.53%. Sides called correctly: 0%.

ExperimentMacro Rotation
ModelDeepSeek
Prompt versionmacro-rotation-v6
Asked
Horizon1-day
Measured from2026-10-16
Measured to2026-10-19
BenchmarkSPY
StatusSettled
Long-short spread-1.53%
Sides called correctly0%
Benchmark return-0.16%

The picks

RankSymbolSidePrice changeReturn in the called directionConfidencevs benchmarkCalled right
1XLVlong-1.34%-1.34%72%-1.18%No
2XLFlong-1.07%-1.07%68%-0.92%No
3TLTlong-0.71%-0.71%65%-0.55%No
4XLKshort+0.74%-0.74%70%-0.59%No
5XLEshort+0.56%-0.56%62%-0.40%No
6XLYshort+0.15%-0.15%58%+0.00%No

The model's market view

The macro backdrop is defined by a hot inflation print (September CPI 3.7% y/y, core 2.6% y/y) that has not stopped long-duration Treasury yields from falling sharply, with the 10-year yield dropping over 10bp to around 5.08%. This divergence reflects a flight to safety driven by an AI/semiconductor sell-off, which is rotating capital out of technology and into defensive sectors, healthcare, and financials. The Fed raised rates to 3.75%-4.00% in September and Chair Warsh gave no clear signal on the next move, leaving markets uncertain. Gold is caught between inflation hedging and a stronger dollar, while energy is retreating from its year-to-date highs. For the one-session window, I expect continued rotation into healthcare and financials, a bounce in long-duration bonds, a further unwinding of the AI trade in technology, and a continued pullback in energy.

Why each pick

XLV

XLV is the strongest beneficiary of the current macro rotation. On October 15, the ETF touched a 52-week high of $178.86 as healthcare stocks gained 1.84% on the day and 2.44% for the week, leading all S&P 500 sectors. Large-cap pharma names like Eli Lilly (+3.6%) and AbbVie (+0.56%) are near record highs on positive clinical data for Skyrizi's subcutaneous formulation, which supports FDA approval and patent extension. The rotation out of AI and semiconductors is a direct tailwind for healthcare as a defensive sector. Risk: if the AI sell-off reverses sharply and risk appetite returns, healthcare could see profit-taking after its recent run. Invalidation: a close below $170 on above-average volume would suggest the rotation is losing steam.

XLF

XLF advanced 1.4% on October 15 and 1.8% earlier in the week as financials continue to benefit from strong Q3 earnings. Major banks like JPMorgan, Bank of America, and Wells Fargo reported strong credit quality and robust double-digit business loan growth despite high rates. Banks are prioritizing lending over buybacks as CET1 ratios decline, which signals confidence in the economic outlook. The rotation out of technology into financials is a clear macro trend, with $784M flowing into XLF while $698M left semiconductor funds. Risk: regional bank exposure and any deterioration in credit conditions could weigh on the sector. Invalidation: a close below $53 on above-average volume would break the recent uptrend.

TLT

TLT is on pace for its best week since March 2025, rising 2.55% to $79.97 by Friday morning, as long-duration Treasury yields fell sharply. The 10-year yield dropped over 10bp to around 5.08% and the 30-year declined 9.7bp to 5.427%, driven by safe-haven demand amid the AI/semiconductor sell-off rather than by inflation data, which was hot. Just nine days ago, TLT traded at $76.43, its lowest price since 2002, so the bounce from deeply oversold levels has room to continue. Risk: ING expects yields to rise to 5.25-5.5% going forward as high inflation and fiscal deficits weigh on the bond market, which could cap TLT's upside. Invalidation: a close below $78 would signal the safe-haven bid is fading.

XLK

XLK is under heavy pressure as the AI trade unravels. The ETF fell 5.8% to $187.26 on Friday, extending a 4.82% slide from $198.78 on October 9 to $189.19 on October 15. Nvidia dropped 1.84%, and the AI debt fears that sparked the sell-off have not fully subsided. Bank of America remains positive on AI-exposed semiconductor companies, which is a contrarian signal, but the near-term momentum is clearly negative. The sector is the worst-performing S&P 500 sector this week, down 3.00% on Thursday alone. Risk: an oversold bounce could be sharp given the magnitude of the decline, and any positive AI news could trigger a short squeeze. Invalidation: a close above $195 on above-average volume would suggest the sell-off is exhausting.

XLE

XLE fell 1.58% to $66.56 on Thursday, retreating from its recent highs after a 49-53% year-to-date gain. Crude oil prices are pulling back, with Brent trading around $104 and WTI near $92-95, and the sector is vulnerable to profit-taking after such a massive run. The energy sector had been the top performer in the S&P 500, but the recent decline in oil prices and the rotation into defensives suggest the momentum is fading. Risk: geopolitical tensions, particularly Houthi strikes, could spike oil prices and lift XLE sharply. Invalidation: a close above $68 on above-average volume would signal renewed energy strength.

XLY

XLY is vulnerable to the rotation out of consumer discretionary as inflation remains hot and real income growth is squeezed. The ETF fell 1.41% to $109.00, underperforming the broader market. September retail sales rose 0.8%, but that was driven by gasoline and autos, not broad-based consumer strength. The AI sell-off and rising uncertainty are likely to weigh on discretionary spending. Risk: a strong consumer sentiment report or a rebound in retail sales could lift XLY. Invalidation: a close above $112 on above-average volume would negate the bearish thesis.

Other models on the same run

ModelPicksLong-short spreadSides called correctly
GPT-6XLK, XLV, XLF, XLC, GLD, XLY-0.90%17%
Gemini 3 ProXLF, GLD, XLP, XLK, TLT, XLE-1.04%17%
Muse Spark 1.1XLV, XLE, XLK, TLT, XLRE, XLP+0.96%83%
PerplexityXLE, XLF, XLU, XLK, XLY, GLD-0.69%33%
Grok 4XLF, XLB, XLV, XLK, XLE, TLT-1.23%17%

Written up on ForecastNest Insights: Macro Rotation: DeepSeek's picks for 2026-10-16.

ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.